P2RX7 and colitis: In line with the anti-tumor activity of P2X7, tumor cell lines appear to grow faster when transferred to P2X7–/– mice (23), and genetic and pharmacological inactivation of P2X7 increases tumorigenesis in the colitis-associated cancer model (18).